A. Bhattacharya

发表

The principal urinary metabolite of allyl isothiocyanate, N-acetyl-S-(N-allylthiocarbamoyl)cysteine, inhibits the growth and muscle invasion of bladder cancer.

R. Munday, F. Geng, Yuesheng Zhang, 2012, Carcinogenesis.

Allyl isothiocyanate-rich mustard seed powder inhibits bladder cancer growth and muscle invasion.

J. Fahey, Yuesheng Zhang, K. Wade, 2010, Carcinogenesis.

Lack of Microvessels in Well-Differentiated Regions of Human Head and Neck Squamous Cell Carcinoma A253 Associated with Functional Magnetic Resonance Imaging Detectable Hypoxia, Limited Drug Delivery, and Resistance to Irinotecan Therapy

Y. Rustum, L. Pendyala, H. Slocum, 2004, Clinical Cancer Research.

Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke: The EXTEND-IA TNK Part 2 Randomized Clinical Trial.

M. Krause, T. Wijeratne, G. Donnan, 2020, JAMA.

PEPD is a pivotal regulator of p53 tumor suppressor

Yuesheng Zhang, A. Bhattacharya, Yun Li, 2017, Nature Communications.

Architectural Heterogeneity in Tumors Caused by Differentiation Alters Intratumoral Drug Distribution and Affects Therapeutic Synergy of Antiangiogenic Organoselenium Compound

C. Morrison, M. Seshadri, Y. Rustum, 2010, Journal of oncology.

Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer

Fengzhi Li, S. Sexton, X. Ling, 2022, Journal of experimental & clinical cancer research : CR.

Inhibition of colon cancer growth by methylselenocysteine-induced angiogenic chemomodulation is influenced by histologic characteristics of the tumor.

M. Seshadri, Y. Rustum, E. Repasky, 2009, Clinical colorectal cancer.

Downregulation of Cystine Transporter xc– by Irinotecan in Human Head and Neck Cancer FaDu Xenografts

M. Yin, Y. Rustum, H. Slocum, 2010, Chemotherapy.

Hypoxia-specific drug tirapazamine does not abrogate hypoxic tumor cells in combination therapy with irinotecan and methylselenocysteine in well-differentiated human head and neck squamous cell carcinoma a253 xenografts.

Y. Rustum, H. Slocum, K. Toth, 2008, Neoplasia.

Strong impact of sulfotransferases on DNA adduct formation by 4‐aminobiphenyl in bladder and liver in mice

H. Glatt, W. Meinl, Zhidan Chen, 2018, Cancer medicine.

Augmented therapeutic efficacy of irinotecan is associated with enhanced drug accumulation.

Y. Rustum, K. Toth, R. Azrak, 2011, Cancer letters.

Inhibition of bladder cancer development by allyl isothiocyanate.

Shang-Chiung Chen, M. Wong, Li Tang, 2010, Carcinogenesis.

Relationship between serum zinc, HOMA2 parameters and glycemic status in a regional Australian hospital population

A. Milton, A. Bhattacharya, Sarah Lim, 2020 .

A plasma proteolysis pathway comprising blood coagulation proteases

Yuesheng Zhang, A. Bhattacharya, Yun Li, 2016, Oncotarget.

Methylselenocysteine – a promising antiangiogenic agent for overcoming drug delivery barriers in solid malignancies for therapeutic synergy with anticancer drugs

A. Bhattacharya, Arup Bhattacharya, 2011, Expert opinion on drug delivery.

Cruciferous Vegetables, Isothiocyanates, and Prevention of Bladder Cancer

Li Tang, J. Marshall, Yuesheng Zhang, 2015, Current Pharmacology Reports.

Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer

M. Fakih, Marwan Fakih, S. Cao, 2006, Expert opinion on pharmacotherapy.

Cruciferous Vegetables, Isothiocyanates, and Prevention of Bladder Cancer

Li Tang, J. Marshall, Yuesheng Zhang, 2015, Current Pharmacology Reports.

Inhibition of ERBB2-overexpressing Tumors by Recombinant Human Prolidase and Its Enzymatically Inactive Mutant

Yuesheng Zhang, A. Bhattacharya, Yun Li, 2015, EBioMedicine.

A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer

Yuesheng Zhang, A. Bhattacharya, Yun Li, 2019, Science Translational Medicine.

Organ-specific exposure and response to sulforaphane, a key chemopreventive ingredient in broccoli: implications for cancer prevention

J. Marshall, Yuesheng Zhang, A. Bhattacharya, 2012, British Journal of Nutrition.

Magnetic resonance and fluorescence-protein imaging of the anti-angiogenic and anti-tumor efficacy of selenium in an orthotopic model of human colon cancer.

M. Seshadri, R. Hoffman, Y. Rustum, 2011, Anticancer research.

Non-Coding Micro RNAs and Hypoxia-Inducible Factors Are Selenium Targets for Development of a Mechanism-Based Combination Strategy in Clear-Cell Renal Cell Carcinoma—Bench-to-Bedside Therapy

Y. Rustum, F. Durrani, Sreenivasulu Chintala, 2018, International journal of molecular sciences.

Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development

Y. Rustum, Y. Zakharia, A. Bhattacharya, 2018, Oncotarget.

Anticoagulants inhibit proteolytic clearance of plasma amyloid beta

Yuesheng Zhang, A. Bhattacharya, Yun Li, 2017, Oncotarget.

PEPD is a pivotal regulator of p53 tumor suppressor

Yuesheng Zhang, A. Bhattacharya, Yun Li, 2017, Nature Communications.

Towards a Better Understanding of Health and Disease

A. Bhattacharya, Arup Bhattacharya, 2012 .

Tumor Vascular Maturation and Improved Drug Delivery Induced by Methylselenocysteine Leads to Therapeutic Synergy with Anticancer Drugs

M. Seshadri, Y. Rustum, K. Toth, 2008, Clinical Cancer Research.

Activity of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid against human head and neck carcinoma xenografts.

M. Seshadri, Y. Rustum, D. Bellnier, 2006, Neoplasia.

Potentiation of irinotecan sensitivity by Se-methylselenocysteine in an in vivo tumor model is associated with downregulation of cyclooxygenase-2, inducible nitric oxide synthase, and hypoxia-inducible factor 1α expression, resulting in reduced angiogenesis

M. Yin, C. Frank, Y. Rustum, 2006, Oncogene.

Enhanced inhibition of urinary bladder cancer growth and muscle invasion by allyl isothiocyanate and celecoxib in combination.

Yi Shi, Yuesheng Zhang, A. Bhattacharya, 2013, Carcinogenesis.

Dual inhibition of ErbB1 and ErbB2 in cancer by recombinant human prolidase mutant hPEPD-G278D

Yuesheng Zhang, A. Bhattacharya, Yun Li, 2016, Oncotarget.

Loss of peptidase D binding restores the tumor suppressor functions of oncogenic p53 mutants

Yuesheng Zhang, A. Bhattacharya, Yun Li, 2021, Communications Biology.